This suggests that the Kif3a mutation may play a compensatory role in a Pkd1-deficient background, thereby alleviating skeletal diseases caused by Pkd1 deletion by inhibiting the differentiation of BMSCs into adipocytes (Qiu et al., 2010). Here, PKD1 is linked to bone disorder.